Some 60 patient advocacy organizations and medical professional societies are calling on Congress and the Trump Administration to end the stalemate and reopen the federal government, saying that the shutdown is cutting into the US Food and Drug Administration’s (FDA’s) ability to ensure that Americans are protected from harm and have access to the latest therapies.